CSF2 and pancreatic adenocarcinoma: reported that in patients with pancreatic adenocarcinoma, injection of granulocyte macrophage colony-stimulating factor-secreting pancreatic tumor cells induced a strong MSLN-specific CD8+ T-cell immune response (53).